Quality Control News and Research

RSS

Nuance releases PowerScribe 360 radiology reporting and communications platform

Nuance Communications, Inc. today announced PowerScribe 360, an advanced radiology reporting and communications platform that combines the best capabilities of PowerScribe and RadWhere into a unified solution. PowerScribe 360 was designed based on feedback and the extensive experience from Nuance's growing list of radiology customers, which today accounts for more than one third of all radiologists in the United States.

29 Nov 2010

NDSsi launches new DOME S10 diagnostic imaging display for mammography screening at RSNA 2010

A highly advanced 10MP diagnostic imaging display capable of showing two 5MP images for back-to-back chest wall reads has been launched by medical technology leader NDS Surgical Imaging (NDSsi). The new 30-inch widescreen Dome S10 supports 10-bit and 8-bit grayscale image data through industry standard interfaces, eliminating the need for proprietary libraries. Featuring non-reflective glass for higher-clarity viewing, and state-of-the-art 4096 x 2560 resolution, the S10 has raised the bar in optical performance in mammography screening.

29 Nov 2010

QIAGEN to supply point-of-need molecular veterinary diagnostics for disease detection in emerging countries

QIAGEN has been selected to contribute to the fight against infectious diseases in animals in emerging countries by supplying an international pilot project associated with the United Nations with portable devices to perform ultra-fast molecular testing in the field.

From QIAGEN Manchester Limited 29 Nov 2010

Elsevier to host 9th Pangborn Sensory Science Symposium

Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced that the 9th Pangborn Sensory Science Symposium has been confirmed, taking place in Kyoto, Japan on 4-8 September 2011.

24 Nov 2010

Daily oral antiretroviral reduces HIV infection risk in MSM by 44%, study finds

A study that included nearly 2,500 HIV-negative men and transgender women who have sex with men has shown that a daily dose of Truvada, a pill containing the AIDS drugs emtricitabine and tenofovir, "can reduce risk of contracting [HIV] by an average of 44% - and by more than 70% if the subjects" follow the regimen closely, Los Angeles Times reports (Maugh, 11/23).

24 Nov 2010

Parkinson Society Canada awards Quebec scientists $573,384 for research

Quebec Parkinson researchers receive a record $573,384 in funding from Parkinson Society Canada to increase their efforts to identify the causes of this degenerative brain disease for which there is currently no cure. At a Research Innovation event in Montreal this evening, hosted by Parkinson Society Quebec in partnership with McGill University and the CHUM, 11 Parkinson scientists will be lauded for their efforts in getting closer to a cure.

23 Nov 2010

AMGA releases comments on draft criteria of ACOs credential

The American Medical Group Association (AMGA), a professional association representing multispecialty medical groups and other organized systems of care, today released its comments on draft criteria for the credentialing of Accountable Care Organizations (ACOs) created by the National Committee for Quality Assurance (NCQA).

23 Nov 2010

CEL-SCI holds clinical investigator meeting for Multikine Phase III clinical trial in head, neck cancer

CEL-SCI Corporation today announced that the Company held a clinical investigator meeting during the week of November 14th for its Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer.

23 Nov 2010

Researchers identify trigger mechanism for quality control checkpoint in cell division process

Researchers from Huntsman Cancer Institute (HCI) at the University of Utah report that they have identified a previously undiscovered trigger mechanism for a quality control checkpoint at the very end of the cell division process in a paper to be published in the November 29 issue of The Journal of Cell Biology and online today.

23 Nov 2010

SESCAM selects WeatherBug weather monitoring solution for emergency services operations

WeatherBug®, the leading provider of consumer and professional weather products and services and operator of the largest weather observing and lightning network, announced its selection by SESCAM (Servicio de Salud de Castilla-La Mancha), a regional healthcare organization in central Spain that serves more than two million living throughout the region of Castilla-La Mancha.

22 Nov 2010

Mammograms bungled: Rush to fix the problem

Nearly 5,300 mammograms will need a review because of a computer error at Breast Screen Victoria. In a serious error a radiologist noticed a mismatch between the names of patients and their images. This may mean that some women may not have had their mammograms checked twice by two different radiologists as is the usual protocol.

17 Nov 2010

Duke awarded $52.8M federal grant to oversee external quality assurance programs for HIV/AIDS labs

The National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), has awarded Duke University Medical Center up to $52.8 million over the next seven years to support the development, implementation and oversight of external quality assurance programs that monitor laboratories involved in HIV/AIDS research and vaccine trials around the world.

17 Nov 2010

MEDecision earns NCQA Healthcare Effectiveness Data and Information Set Software Certification

MEDecision, Inc., a leading provider of collaborative healthcare management solutions, has earned the National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS®) Software Certification for its programs that identify "care opportunities."

15 Nov 2010

Drug industry roundup: Fosamax trial focuses scrutiny on osteoporosis drugs; What about $4 generics; Recalls undermining confidence

The New York Times: A civil trial against the drugmaker Merck is now underway in Manhattan. A retired investigator for the U.S. army is one of 1,400 people suing the company on the premise that Fosamax, a Merck drug used by millions of women with thinning bones, caused them to develop jawbone ailments.

12 Nov 2010

Kaiser Permanente announces 2011 plans for Medicare-eligible beneficiaries

Kaiser Permanente has announced its 2011 plans for individual Medicare-eligible beneficiaries, reflecting its commitment to continuing participation in Medicare in all its existing service areas in nine states and the District of Columbia.

12 Nov 2010

Dead litigant’s family bullied by tobacco company

In 2002 Jamie McCabe’s mother Rolah won a landmark legal battle against British American Tobacco and alleges that the family is still being harassed by the tobacco giant. Ms McCabe became the first Australian to successfully sue a tobacco company. She won $700,000 in compensation after Justice Geoffrey Eames, in the Victorian Supreme Court, found the tobacco company had destroyed potentially relevant documents about the damaging effects of smoking.

11 Nov 2010

NIST develops new Vaccinium berry suite of standard reference materials

National Institute of Standards and Technology (NIST) researchers have developed new certified reference materials for measuring amounts of organic acids in dietary supplements formulated with Vaccinium berries-cranberries, blueberries and bilberries. As described in a recent paper, manufacturers and researchers can use this new suite of standard reference materialsTM (SRMs) as quality assurance tools.

11 Nov 2010

Stafford Hospital inquiry looks into “human rights” violations in care

A public inquiry into conditions and care at Stafford hospital in Stafford, England heard that the hospital was violating basic human rights of the patients. The counsel for Cure the NHS, a campaign group set up by relatives of some of the people who died at the hospital after receiving inadequate treatment established the fact that the standard of care constituted inhuman and degrading treatment at the facility.

10 Nov 2010

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and a financial update for the third quarter ended September 30, 2010.

9 Nov 2010

FDA issues approval letter to Carestream's CR system for mammography

Carestream Health has received an approval letter from the U.S. Food and Drug Administration (FDA) for its high-resolution computed radiography (CR) system for mammography.

7 Nov 2010

Quality Control News and Research

Nuance releases PowerScribe 360 radiology reporting and communications platform

NDSsi launches new DOME S10 diagnostic imaging display for mammography screening at RSNA 2010

QIAGEN to supply point-of-need molecular veterinary diagnostics for disease detection in emerging countries

Elsevier to host 9th Pangborn Sensory Science Symposium

Daily oral antiretroviral reduces HIV infection risk in MSM by 44%, study finds

Parkinson Society Canada awards Quebec scientists $573,384 for research

AMGA releases comments on draft criteria of ACOs credential

CEL-SCI holds clinical investigator meeting for Multikine Phase III clinical trial in head, neck cancer

Researchers identify trigger mechanism for quality control checkpoint in cell division process

SESCAM selects WeatherBug weather monitoring solution for emergency services operations

Mammograms bungled: Rush to fix the problem

Duke awarded $52.8M federal grant to oversee external quality assurance programs for HIV/AIDS labs

MEDecision earns NCQA Healthcare Effectiveness Data and Information Set Software Certification

Drug industry roundup: Fosamax trial focuses scrutiny on osteoporosis drugs; What about $4 generics; Recalls undermining confidence

Kaiser Permanente announces 2011 plans for Medicare-eligible beneficiaries

Dead litigant’s family bullied by tobacco company

NIST develops new Vaccinium berry suite of standard reference materials

Stafford Hospital inquiry looks into “human rights” violations in care

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

FDA issues approval letter to Carestream's CR system for mammography

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News